BSE filing, NSE: TIMKEN. Summary written from the filing by ALFA Finder's alert engine.
Timken India Ltd: key numbers
- Share price
- ₹3,071.50
- Market cap
- ₹23,103 Cr
- Revenue (annual)
- ₹3,478 Cr
- Net profit (annual)
- ₹414.9 Cr
- P/E (TTM)
- 51.0×Sector 52.6×
- Promoter holding
- 51.05%+0.00% QoQ
- FII holding
- 6.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Timken India Ltd
All →Timken India Legal & Regulatory
Timken India's GST appeal was rejected, upholding a Rs 8.19 Crore demand plus interest and penalty. The company plans to appeal and expects no immediate financial impact.
- Value
- ₹8.19 Cr
Timken India Business Update
Timken India received two BIS licences for roller bearings at its Bharuch plants. The licences enable certified supply to regulated sectors, with no financial value disclosed.
Timken India Earnings Call Transcript: Key Takeaways
Timken India delivered strong 25.4% YoY revenue growth, though margins faced pressure from unfavorable segment mix and rising input costs.
Timken India Q2 FY27 Results: Net Profit ₹120.9 Cr, Up 29.2% YoY
Timken India Ltd reported revenue from operations of ₹986 Cr (+25.4% YoY) and net profit of ₹120.9 Cr (+29.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹120.9 Cr · +29.2% YoY
Timken India Other Announcement
Timken India Ltd filed its quarterly shareholding pattern as per SEBI regulations. This routine disclosure details the company's shareholding structure for the quarter ending September 2026.
Timken India Management Change
Timken India announced the appointment of Mr. Pramesh Maheshwari as President of India and Southeast Asia and promoted Mr. Anubhav Khajuria as General Manager - HR.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr